Einstein, M. H., Levin, M. J., Chatterjee, A., Chakhtoura, N., Takacs, P., Catteau, G., . . . Dubin, G. (2014). Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18–45 years: Follow-up through Month 48 in a Phase III randomized study. Hum Vaccin Immunother.
Citação norma ChicagoEinstein, Mark H., et al. "Comparative Humoral and Cellular Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-adjuvanted Vaccine and HPV-6/11/16/18 Vaccine in Healthy Women Aged 18–45 years: Follow-up Through Month 48 in a Phase III Randomized Study." Hum Vaccin Immunother 2014.
MLA CitationEinstein, Mark H., et al. "Comparative Humoral and Cellular Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-adjuvanted Vaccine and HPV-6/11/16/18 Vaccine in Healthy Women Aged 18–45 years: Follow-up Through Month 48 in a Phase III Randomized Study." Hum Vaccin Immunother 2014.